Chief Financial Officer, CN Bio Innovations

Patrick Driscoll is Chief Financial Officer of CN Bio Innovations, the Organ-on-a-Chip technology company transforming drug discovery by offering 3D cell culture solutions and services that generate clinically translatable data in the lab. He holds responsibility for all operational, financial, and legal matters at CN Bio including business development.

Patrick trained and qualified with Deloitte as a Chartered Accountant, working with an array of high-tech and biotech start-ups in Cambridge and London and internationally. Patrick joined CN Bio from Johnson Matthey plc, where he held a number of roles from providing internal audit, advisory and consulting services for manufacturing operations worldwide to operational management of precious metal refineries and commodity trading desks in Europe and North America. During his time with Johnson Matthey, Patrick lived and worked in Salt Lake City for three years.

Dr Driscoll holds a PhD in History from the University of Cambridge, is a Fellow of the Institute of Chartered Accountants of England and Wales, and sits on the East of England Regional Council of the CBI.


20 May 2021